Report of the Panels on Cardiovascular Drugs from the Drug Efficacy Study
E. Freis
DOI: https://doi.org/10.1161/01.cir.41.1.149
IF: 37.8
Circulation
Abstract:*Panel I: Edward D. Freis, M.D., Senior Medical Investigator, Veterans Administration Hospital, Washington, D. C., Chairman; Thomas E. Gaffney, M.D., Director, Division of Clinical Pharmacology, University of Cincinnati College of Medicine, Cincinnati, Ohio; Walter Kirkendall, M.D., Professor of Medicine, University of Iowa College of Medicine, Iowa City, Iowa; Frank I. Marcus, M.D., Professor, Department of Internal Medicine, The University of Arizona College of Medicine, Tucson, Arizona; Mark Nickerson, M.D., Professor, Department of Pharmacology and Therapeutics, McGill University Faculty of Medicine, Montreal, Quebec, Canada; and Morton L. Pearce, M.D., Cardiology Section, Veterans Administration Hospital, Los Angeles, California. Panel II: Sol Sherry, M.D., Professor of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, Chairman; Harriet P. Dustan, M.D., Staff Member, Research Division, Cleveland Clinic Foundation, Cleveland, Ohio; Leon Goldberg, M.D., Associate Professor of Pharmacology and Internal Medicine, Emory University School of Medicine, Atlanta, Georgia; Keith L. MacCannell, M.D., Assistant Professor, Internal Medicine, and Associate Professor, Pharmacology, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada; H. Mitchell Perry, Jr., M.D., Associate Professor of Medicine, Washington University School of Medicine, St. Louis, Missouri; and Abraham M. Rudolph, M.D., Professor of Pediatrics, Cardiovascular Research Institute, University of Califormia School of Medicine, San Francisco, California.